Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
4.61
0.00 (0.00%)
At close: Aug 14, 2025, 3:59 PM
4.33
-6.07%
After-hours: Aug 14, 2025, 07:59 PM EDT
0.00% (1D)
| Bid | 4.19 |
| Market Cap | 27.15M |
| Revenue (ttm) | 14.63M |
| Net Income (ttm) | -11.24M |
| EPS (ttm) | -1.04 |
| PE Ratio (ttm) | -4.43 |
| Forward PE | -6.3 |
| Analyst | Buy |
| Ask | 4.71 |
| Volume | 117,580 |
| Avg. Volume (20D) | 763,319 |
| Open | 4.50 |
| Previous Close | 4.61 |
| Day's Range | 4.50 - 4.81 |
| 52-Week Range | 1.98 - 7.95 |
| Beta | 7.00 |
About VVOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VVOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VVOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Vivos Therapeutics Inc. is scheduled to release its earnings on
Aug 26, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+22.47%
Vivos Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+10.49%
Vivos Therapeutics shares are trading higher after the company announced that the results of its multicenter clinical trial for the treatment of OSA in children using its Daytime-Nighttime Appliance was published in the European Journal of Pediatrics.
3 months ago · seekingalpha.com
Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call TranscriptVivos Therapeutics, Inc. (NASDAQ:VVOS ) Q1 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Brad Amman - CFO Kirk Huntsman - Chairman and CEO Conference Call Participants Do ...
